Search Results 2001-2010 of 16630 for skin%20care

  1. A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer - Mayo Clinic

    ... skin cancer, superficial bladder cancer, or carcinoma in situ of the prostate, cervix, or breast. Participants must not have other active malignancy ...

  2. A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants with Smoldering Multiple Myeloma - Mayo Clinic

    Participation eligibility · Basal cell or nonmetastatic squamous cell carcinoma of the skin · Cervical carcinoma in situ · Ductal carcinoma in situ of the breast ...

  3. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    - Non-melanoma skin cancer - In situ malignancy - Low-risk prostate cancer after curative therapy - Prostate cancer Gleason grade 6 AND with stable prostate ...

  4. A Dose-Ranging Study to Evaluate the Effectiveness and Safety of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex - Mayo Clinic

    Participation eligibility · Patients who cannot carry out the treatment plan or follow-up assessment. · Patients with serious skin lesions such as erosions or ...

  5. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Dr. Cerhan's team in the Lymphoma Epidemiology Lab at Mayo Clinic has expertise in cancer epidemiology, hematology, immunology, laboratory medicine and ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    ... Skin-sparing mastectomy, Nipple-sparing mastectomy, Lymphadenectomy, Oncoplastic breast-conserving surgery, Sentinel lymph node surgery, Modified radical ...

  7. Occupational Medicine - Toxicology Evaluations - Mayo Clinic

    Mayo Clinic offers toxicology evaluations for patients or employers concerned about a work-related chemical exposure causing employee medical issues.

  8. A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants - Mayo Clinic

    Have a history of another malignancy except for basal or squamous cell skin cancer and/or in situ carcinoma of the cervix, or other solid tumors treated ...

  9. Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib - Mayo Clinic

    Diagnosis of another malignancy within 2 years before randomization, except for superficial skin cancers, or localized, low-grade tumors. Participating Mayo ...

  10. Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

    Previous malignancy other than Colorectal cancer (CRC) in the last 5 years except for basal cell cancer of the skin or pre-invasive cancer of the cervix ...